| VCNX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VCNX market cap history going back to 8/14/2018:
Also see: VCNX Shares Outstanding History and VCNX YTD Return |
As of 4/11/2025 Vaccinex has a market cap of 1.87 million. Investors often follow the VCNX market cap history to compare the size of the company over time.
This page shows VCNX market capitalization trends over time, with 27 market cap datapoints presented, dating back to 8/14/2018.

| VCNX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VCNX market cap history going back to 8/14/2018:
Also see: VCNX Shares Outstanding History and VCNX YTD Return |
| VCNX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VCNX Historical Market Cap: -47.19% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| VCNX Stock Price Chart |
| About Vaccinex Inc |
| Vaccinex, Inc. is a clinical-stage biotechnology company. Co. is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical development for the treatment of Alzheimer's disease, head and neck, pancreatic and breast cancer. Its lead platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. We show 27 historical shares outstanding datapoints in our VCNX shares outstanding history coverage, used to compute VCNX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing VCNX market cap history over the course of time is important for investors interested in comparing VCNX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of VCNX versus a peer is one thing; comparing VCNX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like VCNX can fluctuate over the course of history. With this page we aim to empower investors researching VCNX by allowing them to research the VCNX market cap history. |
| VCNX Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| VCNX Share Performance |
| Market Cap Peers |
| Vaccinex (VCNX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
VCYT Market Cap History VERA Market Cap History VERO Market Cap History VERU Market Cap History VERV Market Cap History VICL Market Cap History VIE Market Cap History VIGL Market Cap History VINC Market Cap History VIR Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.